| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysis
|
Yanagisawa, Takafumi
|
|
|
20 |
1 |
p. 57-69
|
artikel
|
| 2 |
Correction: Ivosidenib: A Review in Advanced Cholangiocarcinoma
|
Frampton, James E.
|
|
|
20 |
1 |
p. 181
|
artikel
|
| 3 |
Defining the Position of [177Lu]Lu-PSMA Radioligand Therapy in the Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer: A Meta-analysis of Clinical Trials
|
Ciccarese, Chiara
|
|
|
20 |
1 |
p. 103-112
|
artikel
|
| 4 |
Delayed Separation of Kaplan–Meier Curves is Commonly Observed in Studies of Advanced/Metastatic Solid Tumors Treated with Anti-PD-(L)1 Therapy: Systematic Review and Meta-Analysis
|
Oh, Do-Youn
|
|
|
20 |
1 |
p. 45-56
|
artikel
|
| 5 |
Durvalumab Following Chemoradiotherapy for Stage III Non-small Cell Lung Cancer: Differences in Survival Based on Age and Post-Progression Systemic Therapy
|
Ksienski, Doran
|
|
|
20 |
1 |
p. 149-160
|
artikel
|
| 6 |
Efficacy and Safety of Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Real-World Studies
|
Su, Hui-Chen
|
|
|
20 |
1 |
p. 71-88
|
artikel
|
| 7 |
FGFR-Altered Urothelial Carcinoma: Resistance Mechanisms and Therapeutic Strategies
|
Benjamin, David J.
|
|
|
20 |
1 |
p. 1-11
|
artikel
|
| 8 |
Fruquintinib Plus Sintilimab in Patients with Treatment-Naive and Previously Treated Advanced Renal Cell Carcinoma: Results from a Phase Ib/II Clinical Trial
|
Xu, Hua
|
|
|
20 |
1 |
p. 113-125
|
artikel
|
| 9 |
IDH1/2 Mutations in Cancer: Unifying Insights and Unlocking Therapeutic Potential for Chondrosarcoma
|
Deshmukh, Shriya
|
|
|
20 |
1 |
p. 13-25
|
artikel
|
| 10 |
Immunotherapy Following Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients with Anaplastic Lymphoma Kinase‑Positive Non‑small Cell Lung Cancer in Japan
|
Shimomura, Yuki
|
|
|
20 |
1 |
p. 171-180
|
artikel
|
| 11 |
Open-Label, Multicenter, Phase I Study to Assess Safety and Tolerability of Adavosertib Plus Durvalumab in Patients with Advanced Solid Tumors
|
Patel, Manish R.
|
|
|
20 |
1 |
p. 127-138
|
artikel
|
| 12 |
Optimal Duration of Consolidation Durvalumab Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer: A Multi-institutional Retrospective Study
|
Doi, Hiroshi
|
|
|
20 |
1 |
p. 161-169
|
artikel
|
| 13 |
Post-Metastasis Survival of Patients with High-Risk Localized and Locally Advanced Prostate Cancer Undergoing Primary Treatment in the United States: A Retrospective Study
|
Freedland, Stephen J.
|
|
|
20 |
1 |
p. 139-148
|
artikel
|
| 14 |
Risk and Benefit for Basket Trials in Oncology: A Systematic Review and Meta-Analysis
|
Klas, Katarzyna
|
|
|
20 |
1 |
p. 89-101
|
artikel
|
| 15 |
Unveiling the Digital Evolution of Molecular Tumor Boards
|
Lutz, Sebastian
|
|
|
20 |
1 |
p. 27-43
|
artikel
|
Tijdschrift beschrijving